SCHEMBL6015609

SCHEMBL6015609

COc1ccc(-c2nnc(SCc3ccccn3)[nH]2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.57
CYP1A2 P05177 4/20 0.57
CYP2E1 P05181 4/20 0.57
CYP2C8 P10632 4/20 0.57
CYP2D6 P10635 4/20 0.57
CYP2C9 P11712 4/20 0.57
CYP2B6 P20813 4/20 0.57
CYP2C19 P33261 4/20 0.57
MAPT P10636 4/20 0.57
CYP3A4 P08684 3/20 0.57
ALDH1A1 P00352 3/20 0.57
METAP2 P50579 1/20 0.48
NPC1 O15118 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SYK P43405 5/20 0.46
AURKB Q96GD4 1/20 0.46
INCENP Q9NQS7 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015588 0.89 RAB9A (0.60) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL6015598 0.86 CYP1A2 (0.54) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL6015592 0.86 KDM4E (0.52) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL6015581 0.84 RAB9A (0.58) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL6015607 0.83 CYP1A2 (0.45) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL6015605 0.83 CYP1A2 (0.57) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL6015582 0.83 CYP1A2 (0.57) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL645267 0.81 RAB9A (0.63) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL5446786 0.79 CYP1A2 (0.60) RAB9ACYP1A2CYP2E1CYP2C8CYP2D6
SCHEMBL6405373 0.79 GSK3A (0.50) RAB9ACYP2E1CYP2C8CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054526-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 WO disclosed